Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 9
July 2024
Volume 65, Issue 9
Open Access
ARVO Imaging in the Eye Conference Abstract  |   July 2024
Retinal Nerve Fiber Layer Thickness Prediction from Longitudinal OCT Imaging using Deep Learning
Author Affiliations & Notes
  • JALIL JALILI
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA, USA, California, United States
  • Evan Walker
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA, USA, California, United States
  • Christopher Bowd
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA, USA, California, United States
  • Akram Belghith
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA, USA, California, United States
  • Michael H. Goldbaum
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA, USA, California, United States
  • Massimo A. Fazio
    Department of Ophthalmology and Vision Sciences, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA, Alabama, United States
  • Christopher A. Girkin
    Department of Ophthalmology and Vision Sciences, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA, Alabama, United States
  • Gustavo De Moraes
    Department of Ophthalmology and Vision Sciences, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA, Alabama, United States
  • Jeffrey M. Liebman
    Bernard and Shirlee Brown Glaucoma Research Laboratory, Department of of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, NY, USA, New York, United States
  • Robert N. Weinreb
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA, USA, California, United States
  • Linda Zangwill
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA, USA, California, United States
  • Mark Christopher
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA, USA, California, United States
  • Footnotes
    Commercial Relationships   JALIL JALILI, None; Evan Walker, None; Christopher Bowd, None; Akram Belghith, None; Michael Goldbaum, None; Massimo Fazio, EyeSight Foundation of Alabama (F), GmbH (F), Heidelberg Engineering (F), National Eye Institute (F), Research to Prevent Blindness (F), Topcon (F), Wolfram Research (F); Christopher Girkin, EyeSight Foundation of Alabama (F), GmbH (F), Heidelberg Engineering (F), National Eye Institute (F), Research to Prevent Blindness (F), Topcon (F); Gustavo De Moraes, Belite (C), Carl Zeiss (C), Galimedix (C), Heidelberg (R), Novartis (C), Ora Clinical (E), Perfuse Therapeutics (C), Reichert (C), Topcon (R); Jeffrey Liebman, Allergan (C), Bausch & Lomb (C), Genentech (C), Novartis (F), Research to Prevent Blindness (F), Thea (C); Robert Weinreb, Abbvie (C), Aerie Pharmaceuticals (C), Allergan (C), Bausch & Lomb (F), Carl Zeiss Meditec (F), Carl Zeiss Meditec (P), Centervue (F), Equinox (C), Heidelberg Engineering (F), Iantrek (C), Implandata (C), Nicox (C), Optovue (F), Topcon Medical (C), Topcon Medical (F), Toromedes (P); Linda Zangwill, Abbvie Inc. (C), AISight Health (cofounder and board member) (P), Carl Zeiss Meditec Inc. (F), GmbH (F), Heidelberg Engineering (F), ICare Inc. (F), National Eye Institute (F), Optomed Inc. (F), Optovue Inc. (F), Topcon (C), Topcon Medical Systems Inc. (F), Zeiss (P); Mark Christopher, AISight Health, NEI (F), The Glaucoma Foundation (F)
  • Footnotes
    Support  NEI: R00EY030942, R01EY034146, R01EY029058, R01EY11008, R01EY19869, R01EY027510, R01EY026574, EY018926, P30EY022589, DP5OD029610, R01EY034146, OT2OD032644. Research grant from The Glaucoma Foundation. Unrestricted grant from Research to Prevent Blindness (New York, NY).
Investigative Ophthalmology & Visual Science July 2024, Vol.65, PP008. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      JALIL JALILI, Evan Walker, Christopher Bowd, Akram Belghith, Michael H. Goldbaum, Massimo A. Fazio, Christopher A. Girkin, Gustavo De Moraes, Jeffrey M. Liebman, Robert N. Weinreb, Linda Zangwill, Mark Christopher; Retinal Nerve Fiber Layer Thickness Prediction from Longitudinal OCT Imaging using Deep Learning. Invest. Ophthalmol. Vis. Sci. 2024;65(9):PP008.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To employ a custom deep learning model (one dimensional convolutional neural network, 1D-CNN) to predict future retinal nerve fiber layer (RNFL) thickness based on prior optical coherence tomography (OCT) scans.

Methods : This study utilized optic nerve head (ONH) OCT circle scans (Spectralis, Heidelberg Engineering, Heidelberg, Germany) collected longitudinally from participants in the Diagnostic Innovations in Glaucoma Study (DIGS) and the African Descent and Glaucoma Evaluation Study (ADAGES). From the longitudinal data, input-target series composed of three OCT scans with a gap of 6 – 18 months between each scan were used to train and evaluate models. RNFL thickness measurements from the first two scans of each series were used as model input to predict RNFL thickness in the third scan (Figure 1). Data was split by participant into training / validation (691 input-target series, 357 eyes, 205 patients) and testing (126 input-target series, 80 eyes, 46 patients) sets. The custom 1D-CNN model included was compared to linear regression (LR), support vector regression (SVR), and gradient boosting regression (GBR) models.

Results : The 1D-CNN model significantly outperformed GBR, SVR, and LR in predicting RNFL thickness. (Table 1). For the global and 6 sectoral average thicknesses, it achieved a mean absolute error (MAE) ranging between 2.03μm (global) to 4.64μm (temporal superior), mean relative error (MRE) ranging between 3.27% (global) and 5.44% (TI), and an R-Squared between 0.94 (nasal) an 0.97 (global). The model's predictions were robust and did not show statistically significant variation across different gender, race, and disease severity. In predicting all 768 RNFL thickness measurements from the circle scans, the 1D-CNN and GBR models achieved the highest accuracy (MAE = 6.69μm and 5.21μm, respectively).

Conclusions : This study demonstrates the effectiveness of a custom 1D-CNN model in predicting future RNFL thickness from prior OCT imaging. Accuracy is maintained across different patient demographics and disease severities. The high accuracy in predicting and mapping RNFL thickness changes shows potential for predicting glaucoma progression to improve glaucoma management.

This abstract was presented at the 2024 ARVO Imaging in the Eye Conference, held in Seattle, WA, May 4, 2024.

 

Figure 1: Our method for predicting future RNFL thickness from previous OCT imaging.

Figure 1: Our method for predicting future RNFL thickness from previous OCT imaging.

 

Table 1: Comparison of models to predict global and sectoral RNFL thickness averages.

Table 1: Comparison of models to predict global and sectoral RNFL thickness averages.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×